Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment

Similar documents
The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

Gated blood pool ventriculography: Is there still a role in myocardial viability?

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

MR Assessment of Myocardial Viability

Rational use of imaging for viability evaluation

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

Myocardial viability testing. What we knew and what is new

Imaging and heart failure

Cardiac Imaging Tests

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

Radiologic Assessment of Myocardial Viability

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Old and new insights into viability:perfusion and Perfusion Reserve

CMR stress Perfusion: what's new?

Cardiac magnetic resonance imaging in rheumatoid arthritis: promising or misleading? Sophie Mavrogeni MD FESC

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging

High Risk PCI for Heart Failure

Metabolic Imaging. Magnetic resonance imaging perfusion to assess transmural flow distribution METABOLIC IMAGING - AMEDEO CHIRIBIRI

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Insights into Viability- Function and Contractile Reserve

General Cardiovascular Magnetic Resonance Imaging

Assessment of Ischemia and Viability

Myocardial Stress Perfusion Imaging using CMR

MRI ACS-ben. Tamás Simor MD, PhD, Med Hab. University of Pécs, Heart Institute

Assessment Of Myocardial Viability

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Cardiac MR Cardiac CT

J. Schwitter, MD, FESC Section of Cardiology

Imaging of Coronary Artery Disease: II

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Revascularization of ischemic LV dysfunction: past, present and future

Viability Testing Using Dynamic Echocardiography

Multimodality Imaging in Cardiac Stem Cell Research

DOWNLOAD PDF MYOCARDIAL CONTRAST TWO DIMENSIONAL ECHOCARDIOGRAPHY (DEVELOPMENTS IN CARDIOVASCULAR MEDICINE)

How We Perform Delayed Enhancement Imaging

Assessment of myocardial viability by cardiovascular magnetic resonance imaging

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Current and Future Imaging Trends in Risk Stratification for CAD

Usefulness of Delayed Enhancement by Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy as a Marker of Disease and Its Severity

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Cardiovascular Imaging Stress Echo

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

THE first objective of this thesis was to explore possible shape parameterizations

Impaired Regional Myocardial Function Detection Using the Standard Inter-Segmental Integration SINE Wave Curve On Magnetic Resonance Imaging

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Qualitative and Quantitative Assessment of Perfusion

Validation of echocardiographic 2-dimensional. speckle tracking longitudinal strain imaging for

Cardiac MRI: Cardiomyopathy

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

What the Cardiologist needs to know from Medical Images

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa

Summary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

Echo is Still Strong in Myocardial Viability Wook-Jin Chung, MD, PhD

Value of Assessment of Viable and Ischemic Myocardium and Techniques Such as MRI, Radionuclide Imaging

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Magnetic Resonance Imaging (MRI) for the Assessment of Myocardial Viability

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Original Research. Li-Yueh Hsu, DSc, W. Patricia Ingkanisorn, MD, Peter Kellman, PhD, Anthony H. Aletras, PhD, and Andrew E.

Cardiovascular magnetic resonance in acute myocardial infarction

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

Subha V. Raman, MD, MSEE, FACC, FAHA

Echo in CAD: Wall Motion Assessment

Χ.Τρίκκα Καρδιολογική Κλινική Νοζοκομείο Ερρίκος Νησνάν

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

CARDIAC MRI. Cardiovascular Disease. Cardiovascular Disease. Cardiovascular Disease. Overview

Current Indications for Cardiac MRI: What You See is What You Get?

presenters 2010 Sameh Sabet Ain Shams University

Role of CMR in heart failure and cardiomyopathy

CARDIAC TISSUE CHARACTERIZATION FOLLOWING MYOCARDIAL INFARCTION USING MAGNETIC RESONANCE IMAGING. Jay S. Detsky

1. Introduction VIABILITY D 2005 Taylor & Francis Inc. 481 Order reprints of this article at

Outils d évaluation myocardique par relaxométrie (Myomaps)

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

3D-stress echocardiography Bernard Cosyns, MD, PhD

Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and perfusion

Magnetic Resonance Imaging for the Assessment of Myocardial Viability

The Role of SPECT/ PET

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Perspectives of new imaging techniques for patients with known or suspected coronary artery disease

DECLARATION OF CONFLICT OF INTEREST. Grant support: Philips Healthcare Bayer Schering

Medical Policy. MP Cardiac Applications of Positron Emission Tomography Scanning

Severe Left Ventricular Dysfunction: Evolving Revascularization Strategies

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Classical teaching about myocardial. The Sleeping Heart: Hibernating Myocardium. Introduction

Multiparametric T1, T2 and T2* MR Imaging

Coronary interventions

ASSESSMENT OF CARDIAC AMYLOIDOSIS BY USING 18F-SODIUM FLUORIDE PET/MR IMAGING.

Mechanisms and role of contrast echocardiography

Transcription:

Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment 용환석 고려대학교구로병원영상의학과

Viability Hibernating myocardium a state of myocardial hypocontractility during chronic hypoperfusion, in the presence of completely viable myocardium which recovers functionally upon revascularization. Viable and hibernating myocardium have previously been used interchangeably Mechanism Smart heart hypothesis Repetitive stunning hypothesis

Variable methods J Am Coll Cardiol 2012; 59:359-370.

Variable methods Targets and Modalities Metabolism Perfusion Scar Contractile Reserve CMR X O O O CT X O O X Echo X O Δ O PET O O X X SPECT O O X Δ Functional integrity of myocardial cells Blood flow toward the myocardium Localization and quantification of necrosis/fibrosis Contractile function J Am Coll Cardiol 2012; 59:359-370.

Diagnostic accuracy J Am Coll Cardiol 2012; 59:359-370.

J Am Coll Cardiol 2002; 39:1151-1158.

J Am Coll Cardiol 2002; 39:1151-1158.

Eur Heart J. 2013 Feb 17. [Epub ahead of print]

STICH Viability Sub-study N Engl J Med 2011; 364:1617-1625.

JACC Cardiovasc Imaging 2012; 5:550-558.

Eur Heart J. 2013 Feb 17. [Epub ahead of print]

Eur Heart J. 2013 Feb 17. [Epub ahead of print]

J Am Coll Cardiol 2012; 59:359-370.

CMR: various variables DE-CMR transmural extent of infarction Kim RJ et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453. unenhanced residual rim thickness Ichikawa Y et al. Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol 2005; 45:901-909. LDD-CMR contractile reserve during dobutamine stress Wellnhofer E et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004; 109:2172-2174. Cine CMR end-diastlic wall thikness Kuhl HP et al. Relation of end-diastolic wall thickness and the residual rim of viable myocardium by magnetic resonance imaging to myocardial viability assessed by fluorine-18 deoxyglucose positron emission tomography. Am J Cardiol 2006; 97:452-457. segmental wall thickening of the unenhanced rim Kirschbaum SW et al. Combining magnetic resonance viability variables better predicts improvement of myocardial function prior to percutaneous coronary intervention. Int J Cardiol; 159:192-197.

JACC Cardiovasc Imaging 2012; 5:494-508.

DE CMR Sensitivity Specificity PPV NPV <0% 53 87 77 68 <25% 78 71 70 79 <50% 95 51 69 90 <75% 99 21 52 97 JACC Cardiovasc Imaging 2012; 5:494-508.

Combining viability variables 72 pts with CTO Successful (43/72) or unsuccessful (29/72) PCI Cardiac MRI before and 6 months after PCI 1 Transmural extent of infarction (TEI) 2 Contractile reserve during dobutamine stress 3 End diastolic wall thickness 4 Unenhanced rim thickness 5 Segmental wall thickening of the unenhanced rim(swtur) Int J Cardiol 2012; 159:192-197.

Myocardial Thinning and Scarring 21% JAMA 2013; 309:909-918.

Myocardial Thinning and Scarring 18% JAMA 2013; 309:909-918.

Myocardial Thinning and Scarring JAMA 2013; 309:909-918.

Approaching the Level of Gold Standard Accuracy Basis of segments rather than patients Functional improvement rather than outcome. Clinical availability Cost 국민건강보험공단급여보장부 "4 대중증질환등보장성확대계획수립을위한의견을요청 "

Accuracy Look at dead tissue with scar imaging excellent sensitivity (95%) and NPV (90%) Look at living tissue with dobutamine test excellent specificity (91%) and PPV (93%) JACC Cardiovasc Imaging 2012; 5:494-508.

DE-CMR JACC Cardiovasc Imaging 2012; 5:494-508.

DE-CMR: Potential pitfalls and artefacts Inversion time adjustment (Optimal Myocardial Nulling) Differentiation of subendocardial infarct from blood pool Ghosting artefacts Partial volume effects Quantification of myocardial scar size

Optimal Myocardial Nulling Wrong nulling Optimal nulling PSIR

Bright Blood Cavity Courtesy of Eun-Ah Park, SNUH

Ghost Artifact

Partial Volume Effect 8mm 8mm 0.5 mm Circulation 1999; 100:1992-2002.

Border Zone Circ Cardiovasc Imaging 2010; 3:743-752.

DE MR: Quantification JACC Cardiovasc Imaging 2011; 4:150-156.

DE MR: Quantification JACC Cardiovasc Imaging 2011; 4:150-156.

Reference Myocardium 4.72g 5.49g 4.47g 6.50g 6.92g 4.34g Courtesy of Eun-Ah Park, SNUH

Cine-CMR JACC Cardiovasc Imaging 2012; 5:494-508.

Cine-CMR Accuracy Temporal & Spartial resolution Scan time Quantification Tagging Strain encoded (SENC) JCMR. 2013;15(Suppl 1):E2-E2.

Summary CMR is very accurate modality for assessing myocardial viability. DE-CMR: high sensitivity and NPV LDD-CMR: high specificity and PPV Other methods unenhanced residual rim thickness end-diastlic wall thikness Need quality control and standardization. Image acquisition Measuring, quantification and reporting

감사합니다.